Pirfenidone API

Name	Pirfenidone
Chinese name	吡非尼酮
Cas Number	53179-13-8
Source	India
Qualifications	USDMF/-/-/-/-

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with poor prognosis, and there is still no effective treatment. The new anti-fibrotic drug pirfenidone has been shown to slow down the progression of IPF patients. The listing of pirfenidone has brought new hope to patients with pulmonary fibrosis, and it has also radically changed the situation of clinically incurable disease. According to the latest clinical research results of pirfenidone capsules published in the 2014 annual meeting of the American Thoracic Society and the New England Journal of Medicine, combining the clinical results of more than 1,000 patients in two phase three clinical trials, taking pirfenidone capsules for 12 months Later, it has the effect of prolonging the progression-free survival period, delaying the decline of FVC (the main indicator of lung function), and reducing the risk of death.

Hot Tags: pirfenidone api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Troxagliptin Succinate API, Active Pharmaceutical Ingredient, Pazopanib Hydrochloride Pazopanib API, Fondaparinux API, Vinpocetine API, Pabxilib API

• Previous: Amorolfine Hydrochloride API
• Next: Pinaverium Bromide API